REMERON Side Effects

6797148-3 | Accident, Insomnia, Off Label Use, Surgery, Tongue Disorder
on Jun 10, 2010 Male patient from BRAZIL , weighting 165.3 lb, was diagnosed with insomnia and was treated with Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: accident, insomnia, off label use, surgery (What is surgery?), tongue disorder. Remeron dosage: 30 Mg; Qd; Po. During the same period patient was treated with TYLEX (View Tylex Review and Tylex Label ), COCAINE (View Cocaine Review and Cocaine Label ).

6781671-1 | Chest Discomfort, Dizziness, Dysgeusia, Feeling Drunk, Hypoaesthesia Facial, Hypoaesthesia Oral, Tachypnoea
Patient was taking Remeron (View Usage). Patient had the following side effects: chest discomfort, dizziness (What is dizziness?), dysgeusia, feeling drunk, hypoaesthesia facial, hypoaesthesia oral, tachypnoea on Jun 17, 2010 from UNITED STATES Additional patient health information: Male patient , 39 years of age, weighting 210.0 lb, was diagnosed with major depression and. Remeron dosage: 1 Tablet Daily Po.

6773580-9 | Asphyxia, Completed Suicide, Condition Aggravated, Depression, Dizziness, Dysgeusia, Masked Facies, Restlessness, Thirst
Adverse event was reported on Jun 09, 2010 by a Male patient taking Remeron (View Usage) (Dosage: 15 Mg;qd;po, 30 Mg;qd;po, 15 Mg;qd;po, 15 Mg;qd;po) was diagnosed with depression (What is depression?) and. Location: JAPAN , 73 years of age, weighting 108.0 lb, After Remeron was administered, patient had the following side effects: asphyxia, completed suicide, condition aggravated, depression (What is depression?), dizziness (What is dizziness?), dysgeusia, masked facies, restlessness, thirst. During the same period patient was treated with DEPAS (CON.) (View Depas (con.) Review and Depas (con.) Label ), MAGMITT (CON.) (View Magmitt (con.) Review and Magmitt (con.) Label ), LOXONIN (CON.) (View Loxonin (con.) Review and Loxonin (con.) Label ), ATINES (CON.) (View Atines (con.) Review and Atines (con.) Label ), HALCION (CON.) (View Halcion (con.) Review and Halcion (con.) Label ).

6772229-9 | Ventricular Extrasystoles
on Jun 02, 2010 Male patient from MALAYSIA , 56 years of age, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: ventricular extrasystoles. Remeron dosage: 25 Mg; Po. During the same period patient was treated with ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).


6771478-3 | Agitation, Bipolar I Disorder, Delusion, Diet Refusal, Hallucination, Auditory, Irritability, Overdose, Persecutory Delusion, Pleural Effusion
on Jun 07, 2010 Male patient from JAPAN , 60 years of age, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). Patient had the following side effects: agitation, bipolar i disorder, delusion, diet refusal, hallucination, auditory, irritability, overdose, persecutory delusion, pleural effusion. Remeron dosage: 15 Mg;qd;po 30 Mg;qd;po. During the same period patient was treated with NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), WARFARIN (View Warfarin Review and Warfarin Label ).

6770873-6 | Activation Syndrome, Alcohol Use, Confusional State, Depressed Level Of Consciousness, Memory Impairment, Overdose
Patient was taking Remeron (View Usage). After Remeron was administered, patient had the following side effects: activation syndrome, alcohol use, confusional state, depressed level of consciousness, memory impairment, overdose on Jun 04, 2010 from JAPAN Additional patient health information: Male patient , 45 years of age, was diagnosed with depression (What is depression?) and. Remeron dosage: 15 Mg; Po; 30 Mg;po; 90 Mg;po. During the same period patient was treated with ETISEDAN (View Etisedan Review and Etisedan Label ), MYSLEE (View Myslee Review and Myslee Label ).

6769680-X | Alanine Aminotransferase Increased, Anaemia, Aspartate Aminotransferase Increased, Bilirubin Conjugated Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Cholestatic Liver Injury, Gamma-glutamyltransferase Increased, Renal Failure
Adverse event was reported on May 25, 2010 by a Female patient taking Remeron (View Usage) (Dosage: 15 Mg; Qd; Po) was diagnosed with urinary tract infection (What is urinary tract infection?), q fever and. Location: SWITZERLAND , 84 years of age, weighting 163.1 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, cholestatic liver injury, gamma-glutamyltransferase increased, renal failure. During the same period patient was treated with CIPROFLOX (CIPROFLOXACIN HYDROCHLORIDE) (CIPROFLOXACIN HYDROCHLORIDE) (500 Mg; Bid; Po) (View Ciproflox (ciprofloxacin Hydrochloride) (ciprofloxacin Hydrochloride) Review and Ciproflox (ciprofloxacin Hydrochloride) (ciprofloxacin Hydrochloride) Label ), DAFALGAN (PARACETAMOL /00020001/) (1000 Mg; ; Po) (View Dafalgan (paracetamol /00020001/) Review and Dafalgan (paracetamol /00020001/) Label ), ZOLPIDEM TARTRATE (6.25 Mg; Qd; Po, 12.5 Mg; Qd; Po) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), DISTRANEURINE /00027501/ (View Distraneurine /00027501/ Review and Distraneurine /00027501/ Label ), CIPRALEX /01588502/ (View Cipralex /01588502/ Review and Cipralex /01588502/ Label ), TRANXILIUM (View Tranxilium Review and Tranxilium Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ). Patient was hospitalized.

6769329-6 | Activation Syndrome, Alcohol Use, Confusional State, Depressed Level Of Consciousness, Memory Impairment, Overdose
on Jun 01, 2010 Male patient from JAPAN , 45 years of age, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). Patient had the following side effects: activation syndrome, alcohol use, confusional state, depressed level of consciousness, memory impairment, overdose. Remeron dosage: 15 Mg; Po, 30 Mg; Po, 90 Mg; Po. During the same period patient was treated with ETISEDAN (View Etisedan Review and Etisedan Label ), MYSLEE (View Myslee Review and Myslee Label ).

6769215-1 | Activation Syndrome, Alcohol Use, Confusional State, Depressed Level Of Consciousness, Memory Impairment, Overdose
on May 28, 2010 Male patient from JAPAN , 45 years of age, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). After Remeron was administered, patient had the following side effects: activation syndrome, alcohol use, confusional state, depressed level of consciousness, memory impairment, overdose. Remeron dosage: 15 Mg;po, 30 Mg;po, 90 Mg;po. During the same period patient was treated with ETIZOLAM (View Etizolam Review and Etizolam Label ), MYSLEE (View Myslee Review and Myslee Label ). Patient was hospitalized.

6759719-X | Extrasystoles
Patient was taking Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: extrasystoles on May 21, 2010 from MALAYSIA Additional patient health information: Male patient , 56 years of age, was diagnosed with depression (What is depression?) and. Remeron dosage: 25 Mg Po. During the same period patient was treated with ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

6756697-4 | Initial Insomnia, Product Substitution Issue, Somnolence
Adverse event was reported on Jun 03, 2010 by a Male patient taking Remeron (View Usage) (Dosage: 30 Mg Po Qhs) was diagnosed with sleep disorder (What is sleep disorder?) and. Location: UNITED STATES , weighting 110.0 lb, Patient had the following side effects: initial insomnia, product substitution issue, somnolence.

6755531-6 | Delusion, Diet Refusal, Hallucination, Auditory, Mania, Persecutory Delusion, Pleural Effusion, Pneumonia, Respiratory Failure
on May 21, 2010 Male patient from JAPAN , 60 years of age, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). After Remeron was administered, patient had the following side effects: delusion, diet refusal, hallucination, auditory, mania, persecutory delusion, pleural effusion, pneumonia (What is pneumonia?), respiratory failure. Remeron dosage: 15 Mg;qd; Po; 30 Mg; Qd; Po. During the same period patient was treated with NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), WARFARIN (View Warfarin Review and Warfarin Label ).

6754305-X | Atrioventricular Block Complete
on May 21, 2010 Male patient from MALAYSIA , 73 years of age, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block complete. Remeron dosage: 30 Mg;qd;po. During the same period patient was treated with ZOLPIDEM (View Zolpidem Review and Zolpidem Label ).

6753798-1 | Completed Suicide, Depressed Mood, Fall, Leukoplakia Oral
Patient was taking Remeron (View Usage). Patient had the following side effects: completed suicide, depressed mood, fall (What is fall?), leukoplakia oral on May 26, 2010 from JAPAN Additional patient health information: Female patient , 42 years of age, was diagnosed with depressed mood, suicidal ideation and. Remeron dosage: 15 Mg;qd;po. During the same period patient was treated with MYSLEE (View Myslee Review and Myslee Label ).

6742343-2 | Angioedema, Asthma, Burning Sensation, Conjunctivitis, Erythema, Hepatic Enzyme Increased, Hepatic Steatosis, House Dust Allergy, Oedema Peripheral
Adverse event was reported on May 17, 2010 by a Female patient taking Remeron (View Usage) (Dosage: ) was diagnosed with depression (What is depression?) and. Location: SWEDEN , 35 years of age, After Remeron was administered, patient had the following side effects: angioedema, asthma (What is asthma?), burning sensation, conjunctivitis, erythema, hepatic enzyme increased, hepatic steatosis, house dust allergy, oedema peripheral. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ), LITHITUM (View Lithitum Review and Lithitum Label ), TRIONETTA (View Trionetta Review and Trionetta Label ), KESTINE (View Kestine Review and Kestine Label ), AERIUS (View Aerius Review and Aerius Label ).

6742340-7 | Extrapyramidal Disorder, Hypokinesia, Sinus Bradycardia
on May 17, 2010 Male patient from ITALY , 72 years of age, was diagnosed with depression (What is depression?), myocardial ischaemia and was treated with Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: extrapyramidal disorder, hypokinesia, sinus bradycardia. Remeron dosage: 30 Mg; Qd; Po. During the same period patient was treated with METOPROLOL TARTRATE (50 Mg; Qd; Po) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), PROZAC (10 Mg; Qd; Po) (View Prozac Review and Prozac Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), TRIATEC (View Triatec Review and Triatec Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TOTALIP (View Totalip Review and Totalip Label ). Patient was hospitalized.

6733112-8 | Amnesia, Confusional State, Dry Mouth, Hallucination, Mydriasis, Vision Blurred
on May 09, 2010 Female patient from UNITED STATES , 40 years of age, weighting 122.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?), sleep disorder (What is sleep disorder?) and was treated with Remeron (View Usage). Patient had the following side effects: amnesia, confusional state, dry mouth, hallucination, mydriasis, vision blurred. Remeron dosage: 15 Mg;bid. During the same period patient was treated with WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ).

6732634-3 | Completed Suicide
Patient was taking Remeron (View Usage). After Remeron was administered, patient had the following side effects: completed suicide on May 12, 2010 from JAPAN Additional patient health information: Male patient , 74 years of age, weighting 130.1 lb, was diagnosed with depression (What is depression?) and. Remeron dosage: 30 Mg;qd;po. During the same period patient was treated with OMEPRAL (View Omepral Review and Omepral Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), BONALON (View Bonalon Review and Bonalon Label ), ONEALFA (View Onealfa Review and Onealfa Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ).

6732630-6 | Bradyphrenia, Decreased Appetite, Depressed Level Of Consciousness, Dysuria, Insomnia, Serotonin Syndrome
Adverse event was reported on May 07, 2010 by a Female patient taking Remeron (View Usage) (Dosage: 15 Mg; ; Po, 30 Mg; ; Po, 45 Mg; ; Po) was diagnosed with depression (What is depression?) and. Location: JAPAN , 43 years of age, weighting 77.16 lb, Patient experienced the following unwanted or unexpected effects: bradyphrenia, decreased appetite, depressed level of consciousness, dysuria, insomnia, serotonin syndrome. During the same period patient was treated with SEROQUEL (50 Mg; ; Po) (View Seroquel Review and Seroquel Label ), U PAN (View U Pan Review and U Pan Label ). Patient was hospitalized.

6732628-8 | Completed Suicide
on May 10, 2010 Female patient from JAPAN , 42 years of age, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). Patient had the following side effects: completed suicide. Remeron dosage: 15 Mg; Qd; Po. During the same period patient was treated with MYSLEE (View Myslee Review and Myslee Label ).

6725626-1 | Completed Suicide, Weight Decreased
on May 04, 2010 Female patient from GREECE , 22 years of age, weighting 81.57 lb, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). After Remeron was administered, patient had the following side effects: completed suicide, weight decreased. Remeron dosage: ;qd;. During the same period patient was treated with EFFEXOR (:qd:) (View Effexor Review and Effexor Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), MEDROL (View Medrol Review and Medrol Label ), LOSEC I.V. (View Losec I.v. Review and Losec I.v. Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ).

6719620-4 | Cerebral Disorder, Confusional State, Inappropriate Antidiuretic Hormone Secretion, Neoplasm Malignant
Patient was taking Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral disorder, confusional state, inappropriate antidiuretic hormone secretion, neoplasm malignant on Apr 28, 2010 from SWITZERLAND Additional patient health information: Female patient , 83 years of age, was diagnosed with depression (What is depression?) and. Remeron dosage: 45 Mg; Qd; Po. During the same period patient was treated with LORAZEPAM (2.5 Mg; Qd; Po) (View Lorazepam Review and Lorazepam Label ), DALMADORM (View Dalmadorm Review and Dalmadorm Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ). Patient was hospitalized.

6713060-X | Akathisia, Chest Discomfort
Adverse event was reported on Apr 23, 2010 by a Female patient taking Remeron (View Usage) (Dosage: 15 Mg;qd;po) was diagnosed with depression (What is depression?), insomnia and. Location: JAPAN , 17 years of age, weighting 82.45 lb, Patient had the following side effects: akathisia, chest discomfort. During the same period patient was treated with DEPROMEL (View Depromel Review and Depromel Label ), MAGMITT (View Magmitt Review and Magmitt Label ), RIZE (View Rize Review and Rize Label ), LULLAN (View Lullan Review and Lullan Label ), PARLODEL (View Parlodel Review and Parlodel Label ). Patient was hospitalized.

6710499-3 | Bipolar I Disorder, Delusion, Diet Refusal, Hallucination, Auditory, Irritability, Persecutory Delusion, Pleural Effusion, Pneumonia, Pyrexia
on Mar 31, 2010 Male patient from JAPAN , 60 years of age, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). After Remeron was administered, patient had the following side effects: bipolar i disorder, delusion, diet refusal, hallucination, auditory, irritability, persecutory delusion, pleural effusion, pneumonia (What is pneumonia?), pyrexia. Remeron dosage: 5 Mg;qd;po 30 Mg;qd;po. During the same period patient was treated with NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

6707379-6 | Akathisia, Chest Discomfort
on Apr 23, 2010 Female patient from JAPAN , 16 years of age, weighting 82.45 lb, was diagnosed with depression (What is depression?), insomnia and was treated with Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: akathisia, chest discomfort. Remeron dosage: 18 Mg;qd;po. During the same period patient was treated with DEPROMEL (View Depromel Review and Depromel Label ), MAGMITT (View Magmitt Review and Magmitt Label ), RIZE (View Rize Review and Rize Label ), LULLAN (View Lullan Review and Lullan Label ), PARLODEL (View Parlodel Review and Parlodel Label ). Patient was hospitalized.

6706454-X | Disease Complication
Patient was taking Remeron (View Usage). Patient had the following side effects: disease complication on Apr 21, 2010 from UNITED STATES Additional patient health information: Male patient , 52 years of age, was diagnosed with depression (What is depression?) and. Remeron dosage: 15 Mg; Qd;.

6703497-7 | Blood Creatine Phosphokinase Increased, Burning Sensation, Hyperhidrosis, Muscle Rigidity, Nasopharyngitis, Pyrexia, Serotonin Syndrome, Tachycardia
Adverse event was reported on Apr 20, 2010 by a Female patient taking Remeron (View Usage) (Dosage: 15 Mg;qd;po, 30 Mg;qd;po) was diagnosed with depression (What is depression?) and. Location: JAPAN , 61 years of age, weighting 102.3 lb, After Remeron was administered, patient had the following side effects: blood creatine phosphokinase increased, burning sensation, hyperhidrosis, muscle rigidity, nasopharyngitis, pyrexia, serotonin syndrome, tachycardia. During the same period patient was treated with ZYPREXA (5 Mg; ;po) (View Zyprexa Review and Zyprexa Label ), VALERIN (View Valerin Review and Valerin Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), TETRAMIDE (View Tetramide Review and Tetramide Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), PURSENNID (View Pursennid Review and Pursennid Label ). Patient was hospitalized.

6703495-3 | Cardiac Failure Congestive, Cardiomegaly, Condition Aggravated, Oxygen Saturation Decreased, Pleural Effusion
on Apr 20, 2010 Female patient from JAPAN , 85 years of age, weighting 66.14 lb, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, cardiomegaly, condition aggravated, oxygen saturation decreased, pleural effusion. Remeron dosage: 15 Mg;qd;po, 15 Mg;qd;po. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), SELARA (EPLERENONE) (View Selara (eplerenone) Review and Selara (eplerenone) Label ), CONIEL (View Coniel Review and Coniel Label ), PARIET (View Pariet Review and Pariet Label ). Patient was hospitalized.

6699089-9 | Fatigue, Hepatitis Acute, Sleep Disorder
on Apr 14, 2010 Male patient from GERMANY , 56 years of age, weighting 163.1 lb, was diagnosed with depression (What is depression?), cystitis and was treated with Remeron (View Usage). Patient had the following side effects: fatigue, hepatitis acute, sleep disorder (What is sleep disorder?). Remeron dosage: 0.5 Mg; Qd; Po; 30 Mg; Qd; Po. During the same period patient was treated with RISPERIDONE (250 Mg; Bid; Po) (View Risperidone Review and Risperidone Label ), PARACETAMOL /00020001/ (PARACETAMOL /00020001/) (500 Mg;tid;po; 500 Mg;qid;po) (View Paracetamol /00020001/ (paracetamol /00020001/) Review and Paracetamol /00020001/ (paracetamol /00020001/) Label ), ENAHEXAL /00574902/ (View Enahexal /00574902/ Review and Enahexal /00574902/ Label ), FLUOXETINE HCL (View Fluoxetine Hcl Review and Fluoxetine Hcl Label ), IBUPROFEN TABLETS (View Ibuprofen Tablets Review and Ibuprofen Tablets Label ), OMNIC OCAS (View Omnic Ocas Review and Omnic Ocas Label ). Patient was hospitalized.

6699088-7 | Hepatic Steatosis, Hepatitis Acute
Patient was taking Remeron (View Usage). After Remeron was administered, patient had the following side effects: hepatic steatosis, hepatitis acute on Apr 13, 2010 from GERMANY Additional patient health information: Male patient , 44 years of age, weighting 174.2 lb, was diagnosed with depression (What is depression?), disease recurrence and. Remeron dosage: ; Po. During the same period patient was treated with RISPERDAL (0.5 Mg; Qd; Po) (View Risperdal Review and Risperdal Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), TRAVOR EXPIDET (View Travor Expidet Review and Travor Expidet Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6699077-2 | Asphyxia, Completed Suicide, Dizziness, Dysgeusia, Thirst
Adverse event was reported on Apr 16, 2010 by a Male patient taking Remeron (View Usage) (Dosage: 15 Mg; Qd; Po; 30 Mg; Qd; Po; ;po) was diagnosed with depression (What is depression?) and. Location: JAPAN , 73 years of age, Patient experienced the following unwanted or unexpected effects: asphyxia, completed suicide, dizziness (What is dizziness?), dysgeusia, thirst. During the same period patient was treated with DEPAS (View Depas Review and Depas Label ), MAGMITT (View Magmitt Review and Magmitt Label ), LOXONIN (View Loxonin Review and Loxonin Label ), ATINES (View Atines Review and Atines Label ), HALCION (View Halcion Review and Halcion Label ).

6696709-X | Decreased Appetite, Dysuria, Insomnia, Muscle Tightness, Serotonin Syndrome
on Apr 09, 2010 Female patient from JAPAN , 43 years of age, weighting 77.16 lb, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). Patient had the following side effects: decreased appetite, dysuria, insomnia, muscle tightness, serotonin syndrome. Remeron dosage: 15 Mg; Po, 30 Mg;po, 45 Mg; Po, 30 Mg; Po. During the same period patient was treated with SEROQUEL (50 Mg; Po) (View Seroquel Review and Seroquel Label ), U PAN (View U Pan Review and U Pan Label ). Patient was hospitalized.

6695073-X | Extrapyramidal Disorder, Hypokinesia, Sinus Bradycardia
on Apr 12, 2010 Male patient from ITALY , 72 years of age, was diagnosed with depression (What is depression?), myocardial ischaemia and was treated with Remeron (View Usage). After Remeron was administered, patient had the following side effects: extrapyramidal disorder, hypokinesia, sinus bradycardia. Remeron dosage: 30 Mg;qd;po. During the same period patient was treated with METOPROLOL TARTRATE (50 Mg;qd;po) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TOTALIP (View Totalip Review and Totalip Label ). Patient was hospitalized.

6692278-9 | Depressed Level Of Consciousness, Neuroleptic Malignant Syndrome, Oedema Peripheral
Patient was taking Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, neuroleptic malignant syndrome, oedema peripheral on Apr 08, 2010 from JAPAN Additional patient health information: Female patient , 83 years of age, was diagnosed with depression (What is depression?) and. Remeron dosage: 15 Mg; Qd; Po. During the same period patient was treated with CRESTOR (25 Mg; ; Po) (View Crestor Review and Crestor Label ), AMARYL (View Amaryl Review and Amaryl Label ), CILOSTATE (View Cilostate Review and Cilostate Label ), MICARDIS (View Micardis Review and Micardis Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), RENIVEZE (View Reniveze Review and Reniveze Label ). Patient was hospitalized.

6691452-5 | Asphyxia, Completed Suicide
Adverse event was reported on Apr 08, 2010 by a Male patient taking Remeron (View Usage) (Dosage: 30 Mg; Qd; Po) was diagnosed with depression (What is depression?) and. Location: JAPAN , 42 years of age, weighting 165.3 lb, Patient had the following side effects: asphyxia, completed suicide. During the same period patient was treated with MEILAX (ETHYL LOFLAZEPATE) (1 Mg; ; Po, 2 Mg; Once; Po) (View Meilax (ethyl Loflazepate) Review and Meilax (ethyl Loflazepate) Label ), ABILIT (View Abilit Review and Abilit Label ), DEPAS (View Depas Review and Depas Label ).

6689096-4 | Electroencephalogram Abnormal, Infarction
on Apr 05, 2010 Male patient from JAPAN , 69 years of age, was diagnosed with anxiety (What is anxiety?), depression (What is depression?) and was treated with Remeron (View Usage). After Remeron was administered, patient had the following side effects: electroencephalogram abnormal, infarction. Remeron dosage: 45 Mg;qd;po. During the same period patient was treated with PARIET (CON.) (View Pariet (con.) Review and Pariet (con.) Label ), OPALMON (CON.) (View Opalmon (con.) Review and Opalmon (con.) Label ), MUCOSTA (CON.) (View Mucosta (con.) Review and Mucosta (con.) Label ), MAGLAX (CON.) (View Maglax (con.) Review and Maglax (con.) Label ), BROTIZOLAM (CON.) (View Brotizolam (con.) Review and Brotizolam (con.) Label ), MYSLEE (CON.) (View Myslee (con.) Review and Myslee (con.) Label ).

6687672-6 | Activation Syndrome, Electroencephalogram Abnormal, Infarction
on Apr 05, 2010 Male patient from JAPAN , 69 years of age, was diagnosed with anxiety (What is anxiety?), depression (What is depression?) and was treated with Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: activation syndrome, electroencephalogram abnormal, infarction. Remeron dosage: 45 Mg;qd;po. During the same period patient was treated with PARIET (View Pariet Review and Pariet Label ), OPALMON (View Opalmon Review and Opalmon Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), MAGLAX (View Maglax Review and Maglax Label ), BROTIZOLAM (View Brotizolam Review and Brotizolam Label ), MYSLEE (View Myslee Review and Myslee Label ).

6673779-6 | Back Pain, Epistaxis, Infarction, Pulmonary Embolism, Vein Pain, Weight Decreased
Patient was taking Remeron (View Usage). Patient had the following side effects: back pain (What is back pain?), epistaxis, infarction, pulmonary embolism (What is pulmonary embolism?), vein pain, weight decreased on Mar 29, 2010 from BRAZIL Additional patient health information: Male patient , 25 years of age, weighting 160.9 lb, was diagnosed with mental disorder and. Remeron dosage: Hs; Po. During the same period patient was treated with CLOXAZOLAM (View Cloxazolam Review and Cloxazolam Label ), MELLARIL (View Mellaril Review and Mellaril Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), MAREVAN (View Marevan Review and Marevan Label ).

6670344-1 | Electroencephalogram Abnormal
Adverse event was reported on Mar 29, 2010 by a Male patient taking Remeron (View Usage) (Dosage: 45 Mg;qd;po) was diagnosed with anxiety (What is anxiety?), depression (What is depression?) and. Location: JAPAN , 60 years of age, After Remeron was administered, patient had the following side effects: electroencephalogram abnormal.

6670333-7 | Agitation, Completed Suicide, Family Stress, Gun Shot Wound, Hyperhidrosis, Restless Legs Syndrome
on Mar 22, 2010 Male patient from SWITZERLAND , 37 years of age, was diagnosed with depression (What is depression?), delusion and was treated with Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, completed suicide, family stress, gun shot wound, hyperhidrosis, restless legs syndrome. Remeron dosage: 30 Mg; 45 Mg; 30 Mg;qd;po. During the same period patient was treated with ZYPREXA (5 Mg;po) (View Zyprexa Review and Zyprexa Label ), XANAX (View Xanax Review and Xanax Label ).

6670328-3 | Anaphylactic Shock, Respiratory Disorder
on Mar 26, 2010 Female patient from GERMANY , 87 years of age, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). Patient had the following side effects: anaphylactic shock, respiratory disorder. Remeron dosage: 15 Mg; Once; Po. During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

6669806-2 | Disease Recurrence, Extrapyramidal Disorder, Hypokinesia, Sinus Bradycardia
Patient was taking Remeron (View Usage). After Remeron was administered, patient had the following side effects: disease recurrence, extrapyramidal disorder, hypokinesia, sinus bradycardia on Mar 24, 2010 from ITALY Additional patient health information: Male patient , 72 years of age, . Remeron dosage: 30 Mg;qd;po. During the same period patient was treated with METOPROLOL TARTRATE (50 Mg;qd;po) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), PROZAC (10 Mg;qd;po) (View Prozac Review and Prozac Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), TRIATEC (View Triatec Review and Triatec Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TOTALIP (View Totalip Review and Totalip Label ). Patient was hospitalized.

6666998-6 | Hypoaesthesia, Pain In Extremity, Paraesthesia, Paralysis, Ulnar Nerve Palsy
Adverse event was reported on Mar 23, 2010 by a Male patient taking Remeron (View Usage) (Dosage: Mg; Po, 45 Mg; Po, 30 Mg; Po, 15 Mg; Po) was diagnosed with depression (What is depression?) and. Location: JAPAN , 33 years of age, weighting 158.7 lb, Patient experienced the following unwanted or unexpected effects: hypoaesthesia, pain in extremity, paraesthesia, paralysis (What is paralysis?), ulnar nerve palsy. During the same period patient was treated with MIRTAZAPINE (15 Mg; Qd; Po) (View Mirtazapine Review and Mirtazapine Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), MYSLEE (View Myslee Review and Myslee Label ), DEPROMEL (View Depromel Review and Depromel Label ), LEXOTAN (View Lexotan Review and Lexotan Label ), VEGETAMIN B (View Vegetamin B Review and Vegetamin B Label ).

6662556-8 | Apathy, Condition Aggravated, Feeling Abnormal, Incorrect Dose Administered, Irritability, Suicidal Ideation
on Mar 23, 2010 Male patient from JAPAN , 35 years of age, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). Patient had the following side effects: apathy, condition aggravated, feeling abnormal, incorrect dose administered, irritability, suicidal ideation. Remeron dosage: 15 Mg; Po. During the same period patient was treated with ZOLOFT (100 Mg; Po) (View Zoloft Review and Zoloft Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), MYSLEE (View Myslee Review and Myslee Label ).

6662548-9 | Cardiac Failure Congestive
on Mar 23, 2010 Female patient from JAPAN , 85 years of age, weighting 66.14 lb, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). After Remeron was administered, patient had the following side effects: cardiac failure congestive. Remeron dosage: 15 Mg; Qd; Po. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), SELARA (EPLERENONE) (View Selara (eplerenone) Review and Selara (eplerenone) Label ), CONIEL (View Coniel Review and Coniel Label ), PARIET (View Pariet Review and Pariet Label ). Patient was hospitalized.

6662541-6 | Hypoaesthesia, Pain In Extremity, Paralysis
Patient was taking Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: hypoaesthesia, pain in extremity, paralysis (What is paralysis?) on Mar 19, 2010 from JAPAN Additional patient health information: Male patient , 33 years of age, weighting 158.7 lb, was diagnosed with depression (What is depression?) and. Remeron dosage: 30 Mg; Po 45 Mg; Po 30 Mg; Po 15 Mg; Po. During the same period patient was treated with MIRTAZAPINE (15 Mg; Qd; Po) (View Mirtazapine Review and Mirtazapine Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), MYSLEE (View Myslee Review and Myslee Label ), DEPROMEL (View Depromel Review and Depromel Label ), LEXOTAN (View Lexotan Review and Lexotan Label ).

6656257-X | Neuroleptic Malignant Syndrome
Adverse event was reported on Mar 15, 2010 by a Female patient taking Remeron (View Usage) (Dosage: 15 Mg;qd;po) . Location: JAPAN , 83 years of age, Patient had the following side effects: neuroleptic malignant syndrome. During the same period patient was treated with CRESTOR (25 Mg; ;po) (View Crestor Review and Crestor Label ), AMARYL (View Amaryl Review and Amaryl Label ), CILOSTATE (View Cilostate Review and Cilostate Label ), MICARDIS (View Micardis Review and Micardis Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), RENIVEZE (View Reniveze Review and Reniveze Label ). Patient was hospitalized.

6653984-5 | Hypochondriasis
on Mar 15, 2010 Male patient from JAPAN , 45 years of age, weighting 154.1 lb, was diagnosed with depressive symptom and was treated with Remeron (View Usage). After Remeron was administered, patient had the following side effects: hypochondriasis. Remeron dosage: 30 Mg;qd; Po; 30 Mg; Prn; Po. During the same period patient was treated with DEPROMEL (View Depromel Review and Depromel Label ), AMOXAN (View Amoxan Review and Amoxan Label ).

6653983-3 | Completed Suicide, Depression, Suicidal Ideation
on Mar 16, 2010 Male patient from JAPAN , 46 years of age, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide, depression (What is depression?), suicidal ideation. Remeron dosage: 15 Mg; Po; 30 Mg; Po; 45 Mg; Po . During the same period patient was treated with NELUROLEN (View Nelurolen Review and Nelurolen Label ), SURMONTIL (View Surmontil Review and Surmontil Label ), RESMIT (View Resmit Review and Resmit Label ).

6653967-5 | Activation Syndrome, Completed Suicide, Condition Aggravated, Depression, Elevated Mood, Insomnia
Patient was taking Remeron (View Usage). Patient had the following side effects: activation syndrome, completed suicide, condition aggravated, depression (What is depression?), elevated mood, insomnia on Mar 16, 2010 from JAPAN Additional patient health information: Female patient , 74 years of age, weighting 108.5 lb, was diagnosed with depression (What is depression?) and. Remeron dosage: 15 Mg;po. During the same period patient was treated with PAXIL (View Paxil Review and Paxil Label ), MYSLEE (View Myslee Review and Myslee Label ), TRIAZOLAM (View Triazolam Review and Triazolam Label ), RIZE (View Rize Review and Rize Label ), ABILIT (View Abilit Review and Abilit Label ), RESLIN (View Reslin Review and Reslin Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), HAJIME (View Hajime Review and Hajime Label ).